PYFA Stock Overview
PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
PT Pyridam Farma Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp162.00 |
| 52 Week High | Rp1,545.00 |
| 52 Week Low | Rp138.00 |
| Beta | 0.78 |
| 1 Month Change | -78.54% |
| 3 Month Change | -82.86% |
| 1 Year Change | -81.27% |
| 3 Year Change | -85.97% |
| 5 Year Change | -10.00% |
| Change since IPO | -42.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| PYFA | ID Pharmaceuticals | ID Market | |
|---|---|---|---|
| 7D | -79.1% | -2.3% | -0.6% |
| 1Y | -81.3% | -25.0% | 2.8% |
Return vs Industry: PYFA underperformed the ID Pharmaceuticals industry which returned -25% over the past year.
Return vs Market: PYFA underperformed the ID Market which returned 2.8% over the past year.
Price Volatility
| PYFA volatility | |
|---|---|
| PYFA Average Weekly Movement | 27.1% |
| Pharmaceuticals Industry Average Movement | 3.5% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in ID Market | 12.0% |
| 10% least volatile stocks in ID Market | 2.3% |
Stable Share Price: PYFA's share price has been volatile over the past 3 months.
Volatility Over Time: PYFA's weekly volatility has increased from 17% to 27% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1976 | 1,193 | Yan Gwan Lee | www.pyfa.co.id |
PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia. The company operates in two segments, Pharmaceutical Products, Esthetic, and Toll Manufacturing Services; and Medical Equipments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR – extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper.
PT Pyridam Farma Tbk Fundamentals Summary
| PYFA fundamental statistics | |
|---|---|
| Market cap | Rp92.57b |
| Earnings (TTM) | -Rp85.22b |
| Revenue (TTM) | Rp702.07b |
0.1x
P/S Ratio-1.0x
P/E RatioIs PYFA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PYFA income statement (TTM) | |
|---|---|
| Revenue | Rp702.07b |
| Cost of Revenue | Rp406.75b |
| Gross Profit | Rp295.32b |
| Other Expenses | Rp380.54b |
| Earnings | -Rp85.22b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -159.27 |
| Gross Margin | 42.06% |
| Net Profit Margin | -12.14% |
| Debt/Equity Ratio | 273.3% |
How did PYFA perform over the long term?
See historical performance and comparison